糖尿病

互动

参与AIFA（意大利药品管理局）公众咨询、区域糖尿病工作组，以及就CGM（持续葡萄糖监测）传感器、胰岛素泵和创新药物的获取问题作出贡献。

互动

阅读原始引用

我们定期倡导改善巴基斯坦全国的胰岛素可及性与可获得性。2024年3月，我们组织了一次倡导圆桌会议，随后与DRAP（巴基斯坦药品监管局）进行了多次沟通交流。

We regularly advocate for improved insulin accessibility and availability across Pakistan. In March 2024, we organized an advocacy roundtable, followed by multiple engagements with DRAP. Through these efforts, we highlighted the urgent need for the government to ensure consistent insulin access for people living with diabetes nationwide. By building strong people power and collective advocacy, we were able to drive meaningful government action. As a result, the government signed a contract for the local manufacturing of insulin, marking a major milestone in diabetes care in Pakistan. This public–private collaboration has since led to the launch of insulin products by two local pharmaceutical companies and the initiation of the Chief Minister Punjab Insulin Support Program, which is modeled after Meethi Zindagi’s Program of Insulin (POI).

行动与倡导

阅读原始引用

与市及福利服务县合作，将免费药物治疗扩展至2型糖尿病药物。

Yhteydenpito kaupunkiin ja hyvinvointialueeseen maksuttoman lääkehoidon ulottamiseksi myös tyypin 2 diabeteslääkkeisiin.

行动与倡导

阅读原始引用

将医疗设备（如持续血糖监测仪和胰岛素泵）纳入国家医疗保险目录。

연속 혈당 측정기, 인슐린 펌프 등의 의료 제품의 건강 보험 등재.